Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Matthew Glen Robertson"'
Autor:
Matthew Glen Robertson, Benjamin Bruce Eidenschink, Eriko Iguchi, Stanislav O. Zakharkin, Christopher J. LaRocca, Ezequiel J. Tolosa, Mark J. Truty, Kari Jacobsen, Martin E. Fernandez-Zapico, Julia Davydova
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 659-668 (2021)
Encoding the sodium iodide symporter (NIS) by an adenovirus (Ad) is a promising strategy to facilitate non-invasive imaging and radiotherapy of pancreatic cancer. However, insufficient levels of NIS expression in tumor cells have limited its clinical
Externí odkaz:
https://doaj.org/article/a978dc28a1fd4f84b44bea3c49ac95a1
Autor:
Benjamin Bruce Eidenschink, Martin E. Fernandez-Zapico, Julia Davydova, Stanislav O. Zakharkin, Mark J. Truty, Eriko Iguchi, Christopher J. LaRocca, Ezequiel J. Tolosa, Kari Jacobsen, Matthew Glen Robertson
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 20, Iss, Pp 659-668 (2021)
Molecular Therapy: Oncolytics, Vol 20, Iss, Pp 659-668 (2021)
Encoding the sodium iodide symporter (NIS) by an adenovirus (Ad) is a promising strategy to facilitate non-invasive imaging and radiotherapy of pancreatic cancer. However, insufficient levels of NIS expression in tumor cells have limited its clinical
Autor:
Julia Davydova, Matthew Glen Robertson, Lisa Koodie, Michele Dunning, Richard W. Bianco, Malavika Chandrashekar, G. R. Ruth
Publikováno v:
Cancers
Cancers, Vol 11, Iss 2, p 198 (2019)
Volume 11
Issue 2
Cancers, Vol 11, Iss 2, p 198 (2019)
Volume 11
Issue 2
Oncolytic adenoviruses (Ad) are promising tools for cancer therapeutics. Most Ad-based therapies utilize species C serotypes, with Adenovirus type 5 (Ad5) most commonly employed. Prior clinical trials demonstrated low efficiency of oncolytic Ad5 vect